Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parallel-compound synthesis: methodology for accelerating drug discovery

C N Selway1, N K Terrett

  • 1Discovery Chemistry Department, Pfizer Central Research, Sandwich, Kent, UK.

Bioorganic & Medicinal Chemistry
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Applications of combinatorial chemistry to drug design and development.

Current opinion in drug discovery & development·2009
Same author

Comparison of algorithms for dissimilarity-based compound selection.

Journal of molecular graphics & modelling·1998
Same author

UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic.

Biochemical and biophysical research communications·1989
Same journal

Transport specificity of FpvA and FpvB for pyoverdine-antibiotic conjugates in Pseudomonas aeruginosa.

Bioorganic & medicinal chemistry·2026
Same journal

Design and engineering of μO-conotoxin MfVIA mutants to enhance Na<sub>V</sub>1.8 inhibition and analgesic efficacy in inflammatory pain.

Bioorganic & medicinal chemistry·2026
Same journal

Recent advances in Camptothecin-derived antibody-drug conjugates.

Bioorganic & medicinal chemistry·2026
Same journal

CDK4/6-targeted therapy: From clinical inhibitors to emerging strategies to overcome resistance.

Bioorganic & medicinal chemistry·2026
Same journal

Coumarin-sulfonamide hybrids as PKM2 activators induce metabolic reprogramming and suppress ovarian cancer cell growth.

Bioorganic & medicinal chemistry·2026
Same journal

Recent advances in the development of small-molecule drugs based on covalent reversible inhibitors.

Bioorganic & medicinal chemistry·2026
See all related articles

Parallel compound synthesis rapidly generates numerous compounds, accelerating drug discovery. This efficient method aids in optimizing drug leads and understanding structure-activity relationships for antiviral and neurokinin-2 receptor antagonist development.

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Organic Synthesis

Background:

  • Drug discovery requires efficient synthesis of diverse compound libraries.
  • Lead optimization is a critical bottleneck in developing new therapeutics.
  • Structure-activity relationship (SAR) studies are essential for drug development.

Purpose of the Study:

  • To demonstrate the utility of parallel compound synthesis in accelerating drug discovery.
  • To showcase the application of this methodology in optimizing chemical leads.
  • To generate structure-activity relationship (SAR) data for specific therapeutic targets.

Main Methods:

  • Utilized semiautomated techniques for simultaneous preparation of multiple compounds.
  • Applied parallel synthesis to generate compound libraries for antiviral agents (herpes simplex virus).

Related Experiment Videos

  • Employed parallel synthesis for developing neurokinin-2 receptor antagonists.

    • Main Results:

    • Successfully prepared a large number of individual compounds efficiently.
    • Demonstrated the capability of parallel synthesis to rapidly optimize chemical leads.
    • Obtained valuable structure-activity relationship (SAR) information in the studied therapeutic areas.

    Conclusions:

    • Parallel compound synthesis is a powerful strategy for accelerating lead optimization.
    • This methodology significantly enhances the efficiency of the drug discovery process.
    • Parallel synthesis provides crucial SAR data for developing novel antiviral and neurokinin-2 receptor antagonist drugs.